Please assess the completion status of the following clinical trial:

Trial Title: Cryoablation of Bone Metastases From Endocrine Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* patients with bone metastases from thyroid, adrenal or neuroendocrine tumor diagnosis, associated to one of the following: pain; risk fracture; risk of compression of spinal cord; hypercalcemia; performance status (ECOG) 0-3; mean life expectancy over one month;~Exclusion Criteria:~* age \< 18 years~* active anticoagulant therapy or uncorrectable coagulopathy~* pregnancy or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cryoablation +- cementoplasty treated patients (Type: OTHER): cone beam computed tomography guided cryoablation +- cementoplasty

Based on this trial design, predict the completion outcome and termination type (if applicable).